CureVac GmbH Company Profile

01:27 EST 16th December 2018 | BioPortfolio

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)
For the design of siRNA please use EMBOSS.

Oligonucleotides [order here]: Customized small and large scale production, modifications, and labelling (HPLC purified)

RNActive™ [info] stabilized mRNA for enhanced gene expression:
Custom tailored RNActive™ purified by our proprietary chromatography technology PUREmessenger™


Paul-Ehrlich-Str. 15


Phone: 49 - 70 71 - 9 20 53 - 0
Fax: 49 - 70 71 - 9 20 53 - 11

News Articles [174 Associated News Articles listed on BioPortfolio]

CureVac enters clinical phase with mRNA vaccine

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the initiation of its Phase I dose-escalation clinical trial with the novel mRNA-base...

Die Universität Tübingen verleiht die Ehrensenatorenwürde an Dr. Ingmar Hoerr, Mitgründer und Aufsichtsratsvorsitzenden der CureVac AG

TÜBINGEN, Deutschland und BOSTON, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehmen CureVac AG, Pionier im Bereich mRNA-basierter Impfstoffe und Therapeutika, gratuliert Dr. Ingm.....

CureVac AG: CureVac präsentiert vorläufige Daten seiner Phase-I-Studie mit dem RNA-basierten Wirkstoff CV8102 zur intratumoralen Anwendung auf der 33. Jahrestagung der Society for Immunotherapy of Cancer

Die Daten umfassen CV8102 als Einzelwirkstoff und in Kombination mit einer Anti-PD1-Therapie TÜBINGEN, Deutschland / BOSTON, USA, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Das biopharmazeutische Unternehme.....

Q&A: mRNA’s place in vaccine manufacturing with CureVac

Messenger RNA is demonstrating success in vaccine manufacturing and CureVac is giving it the place to do so with the development of a prophylactic vaccine with mRNA at its core.

Curevac reports another failed cancer vaccine

CureVac inks $1.7bn deal on mRNA cancer vaccines

CureVac to Present at the 19th Annual Piper Jaffray Healthcare Conference

TÜBINGEN, Germany and BOSTON, Nov. 21, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Dan Menichel...

CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations

TÜBINGEN, Germany and BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the appointment o...

PubMed Articles [12 Associated PubMed Articles listed on BioPortfolio]

A comparison of different farrowing systems - Part 1: Effects on the activity of the sow.

The aim of this study was to determine whether a 3-axis accelerometer (MSR 145B V5.106, MSR Electronics GmbH, Seuzach, Switzerland) can continuously record and display the activity behaviour of sows o...

A purpose-designed monofilament-fibre pad for debridement of hard-to-reach wounds: experience in clinical practice.

Effective and comfortable debridement is an important part of managing complex wounds. This user test evaluated a monofilament-fibre pad (with handle) (Debrisoft Lolly, Lohmann & Rauscher GmbH & Co. K...

Field study on loose farrowing in cold barns.

The aim of this field study was to examine the loose farrowing system in view of practicability, particularly to monitor piglet losses and their causes, on a farm proceeding in accordance with the BIO...

Evaluation of the real-world impact of rotational thromboelastometry-guided transfusion protocol in patients undergoing proximal aortic surgery.

Complex aortic procedures are potentially associated with important blood loss and coagulopathy. The aim of this study was to assess the impact of rotational thromboelastometry (ROTEM, Tem Internation...

Evaluation of Physicochemical Properties of New Calcium Silicate-Based Sealer.

This study aimed to evaluate the physicochemical properties of a calcium silicate-based sealer (Sealer Plus BC; MK Life, Porto Alegre, Brazil) compared with an epoxy-resin sealer (AH Plus; Dentsply De...

Clinical Trials [50 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015

The user performance evaluation shows whether people with diabetes are able to obtain accurate measurement results with a blood glucose monitoring system. In this study, user performance e...

Telemedical Examination of a Three-Component Oculomotor Testing Battery

The study investigates the feasibility and safety of the telemedical implementation of three diagnostic oculomotor tests using a video-oculography device and an extended teleconferencing s...

Companies [535 Associated Companies listed on BioPortfolio]

CureVac AG

CureVac is a leading company in the field of messenger RNA (mRNA) technology with more than 17 years’ expertise in handling and optimizing this versatile molecule for medical...

CureVac GmbH

We are dedicated to offering reliable and innovative RNA related products and services to the Life Science Community. siRNA [order here]: ultrapure (HPLC purified)For the design of siRNA please use EM...

Chemie-Kontor GmbH

Chemie-Kontor GmbH trades with chemical specialities for customers in Pharma-, Agro-, Cosmetics and Nutrition Industries and offers a broad range of services. Chemie-Kontor GmbH is agent for: Amberger...

OctreoPharm Sciences GmbH

OctreoPharm Sciences GmbH, located in Berlin (Germany) is a privately held clinical development company focusing on radiopharmaceuticals for the diagnosis and therapeutic control ...

Praher Beteiligungs GmbH

The vision of the company founder Ludwig Praher to produce better and better products of high-grade plastics was the basis for sound growth. Under the direction of Ing. Winfried Praher and Ewald Prahe...

More Information about "CureVac GmbH" on BioPortfolio

We have published hundreds of CureVac GmbH news stories on BioPortfolio along with dozens of CureVac GmbH Clinical Trials and PubMed Articles about CureVac GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CureVac GmbH Companies in our database. You can also find out about relevant CureVac GmbH Drugs and Medications on this site too.

Quick Search


Relevant Topic

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Corporate Database Quicklinks

Searches Linking to this Company Record